Skip Navigation Genome.gov - National Human Genome Research InstituteGenome.gov - National Human Genome Research InstituteGenome.gov - National Human Genome Research InstituteNational Institutes of Health
   
       Home | About NHGRI | Newsroom | Staff
Research Grants Health Policy & Ethics Educational Resources Careers & Training

Home>Research>Intramural Research>Clinical Research>NHGRI Institutional Review Board (IRB) >IRB News and Updates
Print Version

IRB News and Updates

June 12, 2008
May 28, 2008
April 15, 2008
August 15, 2007
March 6, 2007
November 1, 2006
June 26, 2006
June 21, 2006

June 12, 2008

The Genetic Information Nondiscrimination Act (GINA) was signed into law on May 21, 2008. This federal legislation prohibits health insurers and employers from discriminating based on genetic information, including participation in research that involves genetic testing, counseling, or education. The provisions of GINA will take effect in May 2009 (health insurance) and November 2009 (employers). Please see the GINA Quick Guide PDF icon for more information. The NHGRI Institutional Review Board is currently evaluating the impact of GINA on our forms and templates; updates will be posted here over the next year. No changes are currently being requested since the legislation is not yet "in effect."

Top of page

May 28, 2008

Implementation of the new policy regarding "Reimbursement of Travel and Subsistence Expenses for NIH Clinical Research Protocol Participants" is being delayed per Dr. John Gallin, Director of the Clinical Center. The Clinical Center will follow the current process for patient travel until a number of issues are resolved. No actions pertaining to this new policy need to be taken by investigators until further notice.

Top of page

April 15, 2008

New Travel Reimbursement Policy for Research Subjects effective May 1, 2008

NIH has implemented a new policy on reimbursement for travel and subsistence Microsoft Word icon for participants in clinical research trials in the intramural clinical research program. The new policy requires the PI to establish a protocol-specific rate for travel (i.e., local and long-distance transportation) and subsistence (i.e., meals and lodging) ranging from zero up to the full government rate.

Please note: the effective date for this policy is May 1, 2008, for all new and continuing reviews applications.

Updated Conflict-of-Interest Guide, Ethics Clearance, and Consent Statements

The NIH Guide to Preventing Financial and Non-Financial Conflicts of Interest in Human Subjects Research at NIH PDF icon has been updated. The companion ethics Conflict of Interest Form has been renamed Clearance of NIH Investigator Personal Financial Holdings by IC Ethics Office Microsoft Word icon. It is available as a fillable form and should be used effective May 1, 2008. A new Guide to Completing the Ethics Clearance Form PDF icon is also available.

The updated Guide requires investigators to include a statement about conflicts-of-interest review in all informed consent documents. Investigators may select appropriate language from a document of suggested statements.

Transition to electronic web-based Protocol Tracking and Management System

The NHGRI IRB has begun to implement a new protocol tracking and management system (PTMS), which will allow investigators to submit protocols, amendments, and other associated IRB actions via a secure website. Originally developed by NINDS and currently in use by several other NIH IRBs, PTMS will streamline the IRB review process and significantly reduce the amount of paper used in that process.

Please Note: It is important to submit the "Protocol Conflict of Interest Statement" to the NHGRI Deputy Ethics Counselor (DEC) for clearance well in advance of your new and continuing protocol submissions to the IRB. A two-month lead time is suggested in order to ensure that clearance is granted by the time of the IRB meeting at which your protocol will be reviewed. The IRB will not be able to review or approve your protocol until DEC has granted clearance. ***Last minute submissions to the DEC may lead to the suspension of continuing protocols and significant delays in approving new ones.

Investigators will be contacted about the timing and training regarding this new application, which will be phased in over Summer and Fall 2008.

Protocol Template

Please note that the NHGRI IRB Protocol Template Microsoft Word icon and all submission checklists were recently been updated and are posted at the NHGRI IRB website. All new and continuing review submissions must be reformatted according to the new protocol template.

All IRB documentation should be submitted to Victoria Willits, the NHGRI IRB Coordinator, in 10 CRC 6-3340. Place documents in one of the plastic bins just inside the entrance to this office.

Top of page

August 15, 2007 Update

New IRB coordinator, Updated IRB Protocol Template and Checklists

Please note that the NHGRI IRB Protocol Template Microsoft Word icon and all submission checklists have been updated and are posted on this website.

Victoria Willits is our new IRB Coordinator. All IRB documentation should be submitted to her in 10 CRC 6-3340.

Please place documents in one of the plastic bins just inside the entrance to this office.

Top of page

March 6, 2007 Update

Revised Conflict-of-Interest Review by the National Human Genome Research Institute (NHGRI) Deputy Ethics Counselor (DEC)

An updated version of the Guide to Preventing Financial and Non-Financial Conflicts of Research in Human Subjects Research at NIH PDF icon was issued February 25, 2007 by the Director, NIH Clinical Center. Originally issued in October of 2006, the Guide has been reviewed and refined by the Medical Executive Committee, the Human Subjects Research Advisory Committee, and the NIH Ethics Community. The final document has been approved by Raynard S. Kington, M.D., Ph.D., Deputy Director, NIH

Effective immediately, all new and continuing IRB protocols (as well as amendments that involve adding new investigators) will be subject to conflict-of-interest review by the NHGRI Deputy Ethics Counselor (DEC). To obtain review and clearance, PIs should complete and send the Protocol Conflict of Interest Statement PDF icon to the NHGRI DEC at least two months ahead of the continuing review date or anticipated IRB review date for new protocols. This should be done at the time of submission to the SRC for new protocols and triennial reviews.

Send the Protocol Conflict of Interest Statement to:

Barbara Fuller, Deputy Ethics Counselor

National Human Genome Research Institute
National Institutes of Health
9000 Rockville Pike
31 Center Drive
Building 31, Suite 4B09
Bethesda, MD 20892-2154
Phone: (301) 402-0955
Fax: (301) 402-0837
E-mail: barbaraf@mail.nih.gov

Please contact Barbara Fuller or Sara Hull with any questions about this new policy.

Top of page

November 1, 2006 Update

New 1195 and 1195-1 Forms

The NIH Medical Executive Committee and HSRAC have approved updated 1195 PDF icon ("initial review application") and 1195-1 PDF icon("continuing review application") forms. Any Initial Review Applications (NIH 1195) signed by the P.I. on or after November 15, 2006, MUST be submitted on the revised form in order to obtain final approval by the Director, NIH Clinical Center.

Please note some of the key changes to the forms:

  1. Additional protocol designations to better differentiate between types of clinical trials.
  2. Inclusion of technology transfer agreements related to the protocol.
  3. Addition of a conflict of interest review to be conducted by the Deputy Ethics Counselor of the PI's institute.
  4. Addition of the term "Adjunct Principal Investigator" e.g. a PI from outside the NIH. Note that the named PI must still be an NIH employee.

Please contact Sara Hull with any questions about these forms.

Top of page

June 26, 2006

Use of Short Written Consent Forms with Oral Consent

In certain circumstances (e.g., low literacy or illiterate subjects, blind research subjects, unexpected enrollment of non-English speaking subjects), the NHGRI IRB may approve an oral consent process in conjunction with a short written consent form. (See 45 CFR 46.117(b)(2).)

In such cases, the IRB will review and approve:

  1. A written summary of what the PI (or person authorized to obtain consent) will say to the subject or his/her legally authorized representative. The summary must be signed by the person obtaining consent and a witness to the oral presentation.

  2. A short written consent form stating that the required elements of consent as required by 45 CFR 46.116 were presented orally to the subject by the PI (or his/her designate). This short written consent form must be signed by the subject and a witness who observed the presentation of information. In the case of illiterate subjects, "making their mark" is adequate.

The Short Written Consent Form for Non-English Speaking Research Subjects has already been translated into a number of languages. These translated forms are available by contacting IRB Administrator Sara Hull.

Top of page

June 21, 2006

Important Information About IRP Research Involving Stored Human Samples, Specimens or Data

The following letter and related documents clarify that all research involving identified or coded tissues and data must be conducted under an IRB-approved protocol. If an investigator wishes to use samples that were collected under a now-terminated protocol, s/he must either initiate a new protocol or request an exemption from IRB review for this new research activity.

From Dr. Gottesman

If you are conducting research that involves stored human specimens, samples or data, please carefully read the attached two documents. The first specifies a DHHS requirement for continued IRB oversight of all human subjects research, and the second provides details as to how NIH will accomplish this.

Research involving stored identified or coded specimens or data, when IRP investigators can identify the sources, must receive prospective and continuing NIH IRB approval. Any activities that are not consistent with this requirement must stop until NIH IRB approval is granted.

Please note that human subjects research at the NIH must be in compliance with the requirements set forth in the attached documents.

Michael M. Gottesman, M.D.
Deputy Director for Intramural Research
National Institutes of Health

To view the files on this page, you will need Adobe Acrobat Reader. Download Adobe Acrobat Reader

To view the Microsoft Word icon files on this page, you will need MS Word. A copy of the latest version of Word Viewer can be downloaded for free.


Top of page

Last Updated: June 16, 2008



PrivacyCopyrightContactAccessibilitySite MapStaff DirectoryFOIAHome Department of Health and Human Services  National Institutes of Health  USA.gov